Trial intelligence / Profile preview

Simvastatin in aneurysmal subarachnoid haemorrhage

ISRCTN75948817Phase 3Completed

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Start
May 2006
Modality
Small Molecules
01

Overview

Phase 3, randomised trial in subarachnoid hemorrhage (SAH) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Clinical outcome at six months. Started May 2006; status: completed.

02

Drugs

simvastatin
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on ISRCTN75948817.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN75948817.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call